Nektar Stock Blows Up on Encouraging Data to Treat Difficult Cancers Post author:Sam Post published:November 12, 2017 Post category:BioPharma The initial results were presented at the 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting. Source: BioSpace You Might Also Like Most Common Mistake Scientists Make When Applying for a Job July 19, 2017 German Biotech InflaRx Snags $100M in IPO November 8, 2017 Cellect Is Moving To Trade Exclusively On The June 8, 2017